Practice Guidelines for Mild Cognitive Impairment

Updated guidelines offer insights into the prevalence, prognosis, evaluation, and management of MCI.

Sponsoring Organization: American Academy of Neurology

Target Population: Patients in primary, memory disorder, general neurology, geriatric, or psychiatric care

Background and Objective

Mild cognitive impairment (MCI) is associated with cognitive impairment with minimal changes in instrumental activities of daily living. This guideline update focuses on the prevalence, prognosis, evaluation, and management of MCI and its association with Alzheimer disease (AD).

Key Points

Prevalence and Prognosis

The prevalence of MCI increases with age, from 6.7% at ages 60 to 64 years to 25.2% at ages 80 to 84 years. The cumulative incidence of dementia is estimated to be 14.9% after 2 years in people older than 65. Lower educational level also increases the…

Reviewing Author

Jennifer Rose V. Molano, MD

Disclosures

Grant/Research SupportNational Center for Advancing Translational Science – Cincinnati Center for Clinical and Translational Science and Training

Editorial BoardsBrain & Life